相关实验视频

Updated: Jun 14, 2025

Tail Vein Transection Bleeding Model in Fully Anesthetized Hemophilia A Mice
08:13

Tail Vein Transection Bleeding Model in Fully Anesthetized Hemophilia A Mice

Published on: September 30, 2021

6.1K

在患有血友病A的人群中探索抑制剂发育的生物标志物

Meng-Ni Fan1, Tangliang Shen2, Barbara A Konkle3,4

  • 1Center for Immunity & Immunotherapies, Seattle Children's Research Institute, Seattle, Washington, USA.

Research and practice in thrombosis and haemostasis
|June 12, 2025
PubMed
概括

血友病A (HA) 治疗中的抑制剂的生物标志物可能包括特定的细胞因子水平和N-甘氨酸配置文件. 改变的细胞因子和N-甘氨酸模式与HA患者的抑制剂存在有关,有助于风险评估.

关键词:
生物标志物生物标志物细胞因子细胞因子葡萄糖酶化是什么? 葡萄糖酶化是什么?血友病A型 血友病A型 血友病A型抑制剂 抑制剂 抑制剂

更多相关视频

Preparation of Peripheral Blood Mononuclear Cell Pellets and Plasma from a Single Blood Draw at Clinical Trial Sites for Biomarker Analysis07:40

Preparation of Peripheral Blood Mononuclear Cell Pellets and Plasma from a Single Blood Draw at Clinical Trial Sites for Biomarker Analysis

Published on: March 20, 2021

16.6K
Using a GFP-tagged TMEM184A Construct for Confirmation of Heparin Receptor Identity10:41

Using a GFP-tagged TMEM184A Construct for Confirmation of Heparin Receptor Identity

Published on: February 17, 2017

8.0K

相关概念视频

Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
652